ASX: ILU▼ -4.06%
Nov 19, 2026 | Research
Buy, sell-side target A$8.20, 51.3 per cent above the A$5.42 share price. Zircon prices are rising and the Eneabba refinery is 65 per cent built.
ASX: AMC▼ -2.31%
Nov 19, 2026 | Research
Buy: institutional sell-side research has an A$75.55 target on Amcor, 15.7 per cent above the share price of A$65.31, with Berry synergies building.
ASX: NAN▼ -0.67%
Nov 19, 2026 | Research
Buy rated by institutional sell-side research with an A$3.80 target, 27.1 per cent above A$2.99. FY27 guidance affirmed as CORIS advances.
ASX: CKF▼ -0.86%
Nov 18, 2026 | Research
Buy, A$10.70 target, 15.4 per cent above the A$9.27 share price, per institutional sell-side research. KFC Australia steady, Europe improving.
ASX: SUN▼ -0.34%
Nov 17, 2026 | Research
Hold: A$20.50 target, about 0.1 per cent above A$20.47. Suncorp trims FY27 premium growth to around 3 per cent as margins stay supported.
ASX: A2M▲ +0.31%
Nov 17, 2026 | Research
Buy: institutional sell-side target A$8.20 for a2 Milk (ASX: A2M), 11.0 per cent above the share price of A$7.39, as it rebuilds China label sales.
ASX: 360▼ -7.21%
Nov 17, 2026 | Research
Sell-side Buy, A$30.95 target, 41.8 per cent above the share price of A$21.83. Life360 price rises could lift FY27 and FY28 EBITDA by up to 20 per cent.
ASX: MIN▼ -2.45%
Nov 15, 2026 | Research
Hold, A$50.00 sell-side target for Mineral Resources, 5.5 per cent above A$47.41, as record volumes meet softer iron ore and lithium prices.
ASX: RMD▼ -2.66%
Nov 15, 2026 | Research
Buy rated by institutional sell-side research, target A$45.30, about 29.6 per cent above the share price of A$34.96, after a 1Q27 margin beat.
ASX: LYC▼ -2.74%
Nov 14, 2026 | Research
Buy: institutional sell-side target A$18.20 for Lynas Rare Earths is 38.0 per cent above the share price, with floor prices now on over half its output.